The FDA has identified the type of recall as serious, with a risk of medication overdose and death when continuing to use the product, according to a Sept. 16 news release from the agency.
The affected product is the Ivenix LVP Primary Administration Sets Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site. The manufacturer sent affected customers a letter recommending the destruction or return of the affected product and that replacements be requested.
There have been two reported injuries, the release said.
Editor’s note: This article was updated Sept. 18 at 2:45 p.m. CT.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.